<DOC>
	<DOCNO>NCT00893607</DOCNO>
	<brief_summary>Study assess effect 10mg NRL001 mean anal resting pressure ( MARP ) administer slow release suppository apply anal canal rectum . In addition , pharmacokinetics NRL001 plasma , adverse event , change heart rate blood pressure assess .</brief_summary>
	<brief_title>Effect Single Doses 10 mg NRL001 Applied Suppository Anal Canal Rectum</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<mesh_term>Methoxamine</mesh_term>
	<criteria>No previous history anorectal conditions/ diseases No history cardiovascular disease 18 75 year age Males female ( premenopausal female childbearing potential must use adequate contraceptive method negative pregnancy test start study ) Use medication last 30 day vasodilatory activity Use monoamine oxidase inhibitor ( MAOI ) presently within last two week study participation Use medication last 30 day apply anus and/or via rectum ( exception : participation NRL00101/2006 ( SUPP ) previous dose anal canal ) Application unlicensed medication within previous 3 month ( exception : participation NRL00101/2006 ( SUPP ) ) Regular intake 21 unit alcohol per week History evidence cardiovascular disease include ischaemic heart disease hypertension ( define examination : systolic blood pressure great 160mmHg diastolic blood pressure great 90mmHg ; base least two separate reading ) , peripheral vascular disease Raynaud 's syndrome Presence diabetes mellitus History symptom thyroid disease , include hypo hyperthyroidism Pregnant females Breast feed mother Presence concomitant gastrointestinal disease disorder , significant abdominal symptom haemorrhoid also significant organ ( e.g . renal , hepatic cardiac ) dysfunction Volunteers investigator feel would compliant requirement trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>